Study Comparing Clobetasol Cream and Kinsukadi Oil in Treating Skin Reactions Caused by Cosmetic Products

A Randomized Controlled Trial Comparing Clobetasol and Kinsukadi Taila in the Management of Cosmetic-Induced Contact Dermatitis - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/111398

Enrollment

150

Registered

2026-05-29

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L232- Allergic contact dermatitis due tocosmetics

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: History of recent cosmetic use preceding the onset of dermatitis. Clinical diagnosis of contact dermatitis characterized by erythema, itching, vesiculation, or scaling. Willingness to participate and provide written informed consent.

Exclusion criteria

Exclusion criteria: Patients with chronic dermatological conditions such as psoriasis, eczema, or lichen planus. Presence of systemic illnesses or immunocompromised status. Pregnant or lactating women. History of hypersensitivity to the study drugs or similar formulations. Patients currently under corticosteroid or other immunosuppressive therapy.

Design outcomes

Primary

Measure	Time frame
Reduction in key clinical symptoms erythema, itching, vesiculation, and scaling (assessed via a standardized symptom scoring system).Timepoint: 0 weeks, 4 Weeks, 8 Weeks	—

Secondary

Measure	Time frame
Patient-reported improvement in skin comfort and appearance. Incidence of adverse effects (skin irritation, hypopigmentation, recurrence). Comparative overall efficacy and tolerability between groups.Timepoint: 0 weeks, 4 Weeks, 8 Weeks	—

Countries

India

Contacts

Public ContactSahil Arora

GLOCAL UNIVERSITY

drnvimalaajith@gmail.com9447006465

Outcome results